Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06632080Not yet recruiting
Randomised, double-blind trial comparing Substance P with Placebo (2 arms). Primary endpoint: Incidence of Headache at 12 hours. Planned start Oct 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06632080.